Leaflet CO-KARBIS 16mg / 2.5mg tablets


Indicated for: hypertension

Substance: candesartan cilexetil + indapamide (antihypertensive + diuretic)

ATC: C09DA06 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)

Candesartan cilexetil and indapamide are used together for the treatment of high blood pressure, providing more effective blood pressure control. This combination combines an angiotensin II receptor antagonist (candesartan) and a thiazide-like diuretic (indapamide).

Candesartan helps relax blood vessels, while indapamide reduces blood volume by increasing the elimination of water and salt through urine. This leads to lower blood pressure and a reduced risk of cardiovascular complications.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood pressure and electrolyte levels during treatment.

Side effects may include dizziness, fatigue, electrolyte imbalances, or, in rare cases, allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about CO-KARBIS 16mg / 2.5mg

  • Substance: candesartan cilexetil + indapamide
  • Date of last drug list: 01-05-2026
  • Commercial code: W70913012
  • Concentration: 16mg / 2.5mg
  • Pharmaceutical form: tablets
  • Quantity: 28
  • Product type: generic
  • Price: 37.46 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: KRKA D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 15815/2025/12
  • Shelf life: 2 years

Concentrations available for candesartan cilexetil + indapamide

  • 16mg/2.5mg
  • 8mg/2.5mg

Compensation lists for CO-KARBIS 16mg / 2.5mg KRKA

D - Sublist D with 20% discount from the reference price

Price

Copayment

Patient

37.46 RON

7.49 RON

29.97 RON